Cardiology

Andrew Wang, MD

Professor of Medicine
Vice Chief for Clinical Services
Campus mail Duke Box 3428, Durham, NC 27710
Phone (919) 681-1370

Structural heart diseases, including valvular heart disease, hemodynamics, infective endocarditis, and hypertrophic cardiomyopathy

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1995 - 1997
  • Assistant Chief of Service, Medicine, Johns Hopkins University, 1994 - 1995
  • Fellow in Cardiology, Medicine, Duke University, 1993 - 1994
  • Medical Resident, Medicine, Johns Hopkins University, 1990 - 1993
  • M.D., Duke University, 1990

Grants

Publications

Saberi, Sara, Nuno Cardim, Mohamad Yamani, Jeanette Schulz-Menger, Wanying Li, Victoria Florea, Amy J. Sehnert, et al. “Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis.” Circulation 143, no. 6 (February 9, 2021): 606–8. https://doi.org/10.1161/CIRCULATIONAHA.120.052359.

PMID
33190524
Full Text

Olivotto, Iacopo, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, et al. “Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.” Lancet 396, no. 10253 (September 12, 2020): 759–69. https://doi.org/10.1016/S0140-6736(20)31792-X.

PMID
32871100
Full Text

Abdulrahim, Jawan W., Lydia Coulter Kwee, Fawaz Alenezi, Albert Y. Sun, Aris Baras, Teminioluwa A. Ajayi, Ricardo Henao, et al. “Identification of Undetected Monogenic Cardiovascular Disorders.” J Am Coll Cardiol 76, no. 7 (August 18, 2020): 797–808. https://doi.org/10.1016/j.jacc.2020.06.037.

PMID
32792077
Full Text

Ho, Carolyn Y., Matthew E. Mealiffe, Richard G. Bach, Mondira Bhattacharya, Lubna Choudhury, Jay M. Edelberg, Sheila M. Hegde, et al. “Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.” J Am Coll Cardiol 75, no. 21 (June 2, 2020): 2649–60. https://doi.org/10.1016/j.jacc.2020.03.064.

PMID
32466879
Full Text

Pineda, Andrés M., Jennifer Rymer, Alice Wang, Adam Z. Banks, Lynne H. Koweek, Ryan Plichta, Adam Williams, et al. “Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.” Am Heart J 224 (June 2020): 105–12. https://doi.org/10.1016/j.ahj.2020.02.003.

PMID
32361278
Full Text

Ho, Carolyn Y., Iacopo Olivotto, Daniel Jacoby, Steven J. Lester, Matthew Roe, Andrew Wang, Cynthia Burstein Waldman, David Zhang, Amy J. Sehnert, and Stephen B. Heitner. “Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy.” Circ Heart Fail 13, no. 6 (June 2020): e006853. https://doi.org/10.1161/CIRCHEARTFAILURE.120.006853.

PMID
32498620
Full Text

Writing Committee Members, Eric S., Clyde W. Yancy, Mark H. Drazner, Samuel Tristram Coffin, William Cornwell, Shashank Desai, John P. Erwin, et al. “2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.” J Card Fail 26, no. 3 (March 2020): 254–69. https://doi.org/10.1016/j.cardfail.2020.01.008.

PMID
32081473
Full Text

Rymer, Jennifer A., Zhuokai Li, Morgan L. Cox, Muath Bishawi, Andrzej S. Kosinski, David J. Cohen, Andrew Wang, et al. “Pre- Versus Post-Procedure Health Care Resource Utilization in Patients Undergoing Commercial Transcatheter Mitral Valve Repair.” Jacc Cardiovasc Interv 12, no. 23 (December 9, 2019): 2416–26. https://doi.org/10.1016/j.jcin.2019.09.056.

PMID
31734302
Full Text

Wang, Andrew. “Statement from the International Collaboration on Endocarditis on the current status of surgical outcome in infective endocarditis.” Ann Cardiothorac Surg 8, no. 6 (November 2019): 678–80. https://doi.org/10.21037/acs.2019.05.19.

PMID
31832359
Full Text

Wang, A., S. B. Heitner, D. Jacoby, S. Lester, L. Fang, G. Balaratnam, and A. J. Sehnert. “Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study.” In European Heart Journal, 40:65–65. OXFORD UNIV PRESS, 2019.

Scholars@Duke

Pages